Next-generation technology is a critical mid-step in dementia care
The past few years have seen outstanding progress in medication for previously incurable conditions. Most pertinent for me is the approval of lecanemab for use in the UK and elsewhere to slow the progress of early-stage Alzheimer’s disease. It isn’t...









